School of Medicine
Showing 11,701-11,800 of 12,199 Results
-
Courtney Wusthoff, MD
Associate Professor of Neurology and, by courtesy, of Pediatrics (Neonatology)
Current Research and Scholarly InterestsMy projects focus on clinical research in newborns with, or at risk, for brain injury. I use EEG in at-risk neonates to better understand the underlying pathophysiology of risk factors that may lead to worse outcomes. I am particularly interested in neonatal seizures and how they may exacerbate perinatal brain injury with a goal to identify treatments that might protect the vulnerable brain. I am also interested in EEG in other pediatric populations, as well as medical ethics and global health.
-
Joanna Wysocka
Lorry Lokey Professor and Professor of Developmental Biology
Current Research and Scholarly InterestsThe precise and robust regulation of gene expression is a cornerstone for complex biological life. Research in our laboratory is focused on understanding how regulatory information encoded by the genome is integrated with the transcriptional machinery and chromatin context to allow for emergence of form and function during human embryogenesis and evolution, and how perturbations in this process lead to disease.
-
Tony Wyss-Coray, PhD
D. H. Chen Professor II
Current Research and Scholarly InterestsUse of genetic and molecular tools to dissect immune and inflammatory pathways in Alzheimer's and neurodegeneration.
-
Zhen Xiao
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsApplying magnetic nanomaterials for bioimaging and cancer treatment
-
James Xie
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. James Xie is a pediatrician and pediatric anesthesiologist at Stanford University School of Medicine. His goal is to improve patient care with health information technologies. Currently he is a clinical informatics physician (CI-MD) and Epic physician builder at Stanford Children's Health.
Dr. Xie studied computer science and medicine at Stanford University, followed by a combined residency in general pediatrics at Boston Children's Hospital and Boston Medical Center and anesthesiology at Brigham and Women's Hospital. After residency, he completed a fellowship in pediatric anesthesiology at Stanford Children's Health where he subsequently joined the faculty as a Clinical Assistant Professor. -
Lei Xing
Jacob Haimson and Sarah S. Donaldson Professor and Professor, by courtesy, of Electrical Engineering
Current Research and Scholarly Interestsartificial intelligence in medicine, medical imaging, Image-guided intervention, molecular imaging, biology guided radiation therapy (BGRT), treatment plan optimization
-
Adam Z. Xu
Affiliate, Ophthalmology Research/Clinical Trials
BioStudying retinal ganglion cell (RGC) neuroprotection & axon regeneration with the Hu Lab, https://med.stanford.edu/hulab.html
-
Shiqin Xu
Masters Student in Clinical Informatics Management, admitted Summer 2022
Senior Manager, Courses and Global Programs, School of Medicine - MDRP'S - Biodesign ProgramCurrent Role at StanfordSenior Manager, Courses and Global Programs, Stanford Biodesign
-
Shin Yajima
Postdoctoral Scholar, Cardiothoracic Surgery
BioI am a board-certified attending cardiothoracic surgeon in Japan. Throughout my clinical experience and research, I found that insufficient myocardial blood flow had little impact on myocardial functional recovery since percutaneous coronary intervention or coronary artery bypass grafting (CABG) could approach and supply blood flow to the superficial large coronary arteries, but not to intramyocardial microvascular arteries, particularly where microvasculature was either scarce or absent. In addition, myocardial ischemia-reperfusion (I/R) adversely affected cardiac functional recovery in ischemic hearts, including transplanted hearts. Therefore, I have a keen interest in addressing myocardial microvascular dysfunction and myocardial I/R injury in research.
During my Ph.D. in cardiovascular surgery, I focused on a prostacyclin analog that has thromboxane A2 synthase inhibitory activity and can promote angiogenesis and restore myocardial blood flow through proangiogenic and vasodilatory effects. I applied a microform of this compound in the porcine ischemia cardiomyopathy model with a direct epicardial placement, elucidating promoted myocardial angiogenesis, leading to myocardial function recovery. Then, I developed nanoparticles (NPs) that incorporated this compound which I subsequently applied to a rat ischemia myocardial reperfusion model with intravenous injection to elucidate attenuated myocardial I/R injury with selective accumulation in the ischemic myocardium, better-preserved capillary networks, a better-preserved myocardial blood flow, and a smaller infarct size. Furthermore, I have worked on tissue engineering for myocardial regeneration using induced pluripotent stem cells (iPSCs) and adipose-derived mesenchymal stem cells. With human iPSCs-derived cardiomyocyte sheets of direct implantation on the ischemic myocardial tissue, we elucidated myocardial regeneration through thickened myocardial tissue, proangiogenic effects, improved cardiac performance, and attenuated left ventricular remodeling in both small and large animals. These works have already been published (below are representative), and I gained several academic awards and research grants (ongoing research support; Japan Heart Foundation/Bayer Research Grant Abroad, 01/01/2022 - 12/31/2022).
My career goal is to become a leader in academic cardiovascular surgery. During my postdoctoral fellowship, I plan to develop novel therapeutic methods to obtain better outcomes for ischemic heart disease in which there is room for improvement through engineering analysis and the creation of innovative solutions. I am extremely excited to start on the proposed project, as it perfectly intertwines my bioengineering background and clinical interests. As such, the School of Medicine Dean's Postdoctoral Fellowship will be invaluable to my development as a young investigator. Dr. Woo is an exceptional mentor with remarkable renown for training academic surgeons and Stanford University provides incredible resources for research. I feel extremely fortunate to have such an ideal environment to carry out this project and continue advancing the field of cardiothoracic surgery through bioengineering. -
Yasuaki Yanagawa
Postdoctoral Scholar, Infectious Diseases
BioRNAseq for Entaoeba histolytica
-
Fan Yang
Associate Professor of Orthopaedic Surgery and of Bioengineering
Current Research and Scholarly InterestsOur research seeks to understand how microenvironmental cues regulate stem cell fate, and to develop novel biomaterials and stem cell-based therapeutics for tissue engineering and regenerative medicine. Our work spans from fundamental science, technology development, to translational research.We are particularly interested in developing better therapies for treating musculoskeletal diseases, cardiovascular diseases and cancer.
-
Lu Yang
Affiliate, Dean's Office Operations - Dean Other
Resident in PathologyBioPhysician-scientist with broad interests in genetics/genomics, cell biology, developmental biology, cancer, clinical pathology, bioinformatics, and computer vision.
-
Ming Yang
Postdoctoral Scholar, Ophthalmology
BioOphthalmology
-
Phillip C. Yang, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.
-
Priscilla Li-ning Yang
Professor of Microbiology and Immunology
BioPriscilla earned her PhD in Bio-organic Chemistry at the University of California, Berkeley. Following postdoctoral training in viral immunology at Scripps Research, she started her independent career at Harvard Medical School, where her laboratory combined chemical and pharmacological approaches to address fundamental and translational problems in virology. She is currently Professor in the Department of Microbiology and Immunology and the Stanford University School of Medicine where she focuses on leading and mentoring a multidisciplinary group of scientists focused on discovery and validation of new antiviral targets; identifying new strategies to achieve broad-spectrum activity and to avoid antiviral resistance; and investigating the function of lipid membranes in RNA virus replication. She is a strong advocate for diversity, equity, and inclusion in science.
